Replies to post #57181 on Biotech Values

[DewDiligence]

>Is IDX184 first-in-class?<

That depends on what the definition of class is :-)

Seriously, I’m not aware of another HCV drug in development that’s a nucleotide prodrug with the properties that IDX184 has.

Read the table in #msg-25836105 and decide for yourself. Or, better yet, listen to the JPM webcast replay, which comes with very detailed slides.